
USDJPY, Nasdaq Forecast: Rate Hold Expectations Pressure Markets
USDJPY, Nasdaq Forecast: The Japanese Yen is back at BOJ intervention risk levels, and the Nasdaq is struggling below the 22,000-threshold with a more hawkish-than-expected Fed tone. Non-farm payrolls, earnings, and inflation metrics are the next key events likely to shift the market tone.
Share this:
Article Outline
- Key Events: Fed Rate Expectations, Tech Sector, and Non-Farm Payrolls
- Technical Analysis: USDJPY and Nasdaq (3-Day Time Frame)
- Technical Analysis (TA) Tip: Forecasting with Fibonacci Tools
2025 Fed Rate Expectations
According to the CME Fed Watch Tool, the market leans toward a 95% probability of a rate hold at the January meeting, reflecting the more hawkish-than-expected stance in the FOMC minutes regarding the rate cut trajectory for 2025. Global central banks are expressing inflation concerns tied to Trump’s presidency, leading to a cautious approach to rate cuts in 2025.
Source: CME Fed Watch Tool
Meanwhile, the strength of the US Dollar Index continues to pressure global currencies, while US indices face bearish momentum amid 2025 uncertainties. Earnings results later this month are expected to increase volatility risks for US indices. A positive performance in the tech sector may spur another Nasdaq rally despite ongoing market challenges in 2025.
USDJPY
In currency markets, the strong dollar exerts significant pressure on global currencies, particularly the Japanese Yen, which is approaching record lows and raising BOJ intervention risks. The USDJPY pair is currently trading near 158, with the 160-level looming ahead. This critical level could prompt BOJ intervention, triggering potential volatility spikes.
Technical Analysis: Quantifying Uncertainties
USDJPY Forecast: 3Day Time Frame – Log Scale
Source: Tradingview
The USDJPY pair reflects bullish potential, maintaining alignment with its primary up trending channel since 2023 and trading above its 21-day SMA. Using the Fibonacci extension tool applied to the 2023 low, 2024 high, and 2024 low, the levels of 0.236 and 0.5 align with key levels at 148.60 and 156.70.
The next significant level, at the 0.618 Fibonacci extension, aligns with the 160-mark, where the RSI is expected to reach extreme overbought levels, increasing the risk of BOJ intervention and potential reversals.
On the downside, 156.70 and 155.50 act as key support levels, aligning with the trendline connecting consecutive lows from January 2023 to August 2024. A break below these levels and the primary trendline could deepen bearish sentiment, with the next support levels anticipated around 153.50 and 149, signaling potential Yen strength recovery.
Nasdaq Forecast: 3Day Time Frame – Log Scale
Source: Tradingview
The Nasdaq's uptrend continues to respect the borders of its primary ascending channel, established from the 2022 lows. Applying the Fibonacci retracement tool to the uptrend from the August 2024 low (17,200) to the 2024 high (22,130), potential declines below the 20,700-mark can be assessed.
The recent low at 20,780 found support at the channel's bottom border and the July 2024 high. A break below the 20,700 support is necessary to shift sentiment toward bearish territory, with further declines potentially extending toward 20,200, 20,000, and 19,700.
On the upside, applying the Fibonacci extension tool to the March 2023 low, July 2024 high, and August 2024 low, a sustained close above the 21,800 or 22,000-mark could trigger a rally toward the 0.618 Fibonacci extension level near 22,880.
Written by Razan Hilal, CMT
Follow on X: @Rh_waves
On You tube: Forex.com
Related tags:
Latest market news
View more newsOpen an account today
Experience award-winning platforms with fast and secure execution.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.

USD/JPY: The 160.00 Test
The dual intervention from July continues to cast a shadow over USD/JPY, but with a fundamental backdrop that seemingly won’t give way, bulls have continued to press right back up to a major level in the pair.

Nasdaq 100 forecast: Markets turn jittery as Anthropic debuts at 34% above IPO
Nasdaq futures were up some 2% earlier, but shortly after the Anthropic debut, the index slumped to session lows, down more than 1.5%, before bouncing back from the lows at the time of writing. Much of the selling for the Nasdaq was driven by AMD which slumped nearly 10% after a Hunterbrook Media report raised fresh questions about the company’s exposure to US export controls on China.

S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
Stocks continue to turn in Q4 and the post-earnings bounce from NVDA has been faded, while the S&P 500 grasps on to a support level with a large amount of open space below.
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.




